Multifunctional Tannins from Phyllanthus amarus Exhibit Disease-Modifying Activities Against Alzheimer's Pathogenesis: An In Vitro and In Vivo Investigation

Topic: Brain proteins, microglia and lab models

Alzheimer's disease (AD) manifests as a chronic neurodegenerative syndrome featuring cognitive impairment alongside characteristic neuropathological markers: amyloid-beta (Aβ) plaques and tau-associated neurofibrillary tangles. Absence of curative interventions necessitates exploration of novel therapeutic candidates. Phyllanthus amarus, recognized for its phytochemical diversity including tannins and lignans, demonstrates antioxidant and neuroprotective bioactivities warranting AD-focused investigation. This investigation employed systematic extraction and characterization of tannins from Phyllanthus amarus, subsequently evaluating their anti-Alzheimer properties through cellular and transgenic animal models. Experimental data revealed substantial neuroprotective effects, including suppression of Aβ aggregation and mitigation of neuroinflammatory processes. Behavioral studies in AD-model mice demonstrated cognitive function restoration following tannin administration. Molecular analyses identified modulation of key pathological pathways, specifically amyloid precursor protein processing regulation and oxidative stress amelioration. Findings validate Phyllanthus amarus tannins as promising disease-modifying candidates for Alzheimer's therapy. This research strengthens the scientific rationale for phytochemical-based neurotherapeutic development, presenting viable strategies for addressing neurodegenerative conditions.

Key findings

• Experimental data revealed substantial neuroprotective effects, including suppression of Aβ aggregation and mitigation of neuroinflammatory processes.
• Behavioral studies in AD-model mice demonstrated cognitive function restoration following tannin administration.

Why it matters

Tannins extracted from Phyllanthus amarus suppressed Aβ aggregation, reduced neuroinflammation and restored cognitive function in AD-model mice. This is cellular and animal work, so it supports further research but does not yet provide a proven therapy for patients.

New to this subject? Start with our plain-English guide: Genetics →

Study details

• Evidence strengthLow

Read the original

• DOI: 10.61096/ijpar.v15.iss1.2026.80-94
• Original source →

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

@article{pol2026-af9354a9,
  author  = {Pol, Rahul P. and Purane, Laxmikant Maruti and Kane, S. R. and Misal, A. A. and Yadav, Akshay R. and Chopade, Atul R. and Sarvagod, S.M. and Jadhav, P. D.},
  title   = {{Multifunctional Tannins from Phyllanthus amarus Exhibit Disease-Modifying Activities Against Alzheimer's Pathogenesis: An In Vitro and In Vivo Investigation}},
  journal = {IJPAR JOURNAL},
  year    = {2026},
  doi     = {10.61096/ijpar.v15.iss1.2026.80-94},
  url     = {https://doi.org/10.61096/ijpar.v15.iss1.2026.80-94}
}

Related studies in Risk genes beyond APOE

• In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis Neurobiology of aging · 1996-09-01 · usefulness score 47/100
• Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies The Journal of biological chemistry · 2012-11-15 · usefulness score 46/100
• The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo The Journal of neuroscience : the official journal of the Society for Neuroscience · 2003-07-01 · usefulness score 44/100
• RAC1 inhibition targets amyloid precursor protein processing by gamma-secretase and decreases Abeta production in vitro and in vivo The Journal of biological chemistry · 2005-09-08 · usefulness score 41/100
• Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo Neuron · 1996-11-01 · usefulness score 36/100
• Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents Journal of medicinal chemistry · 2014-03-10 · usefulness score 43/100

Also tagged “double-blind”

783 studies in the library carry the topic tag “double-blind”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.

• Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial Pharmacopsychiatry · 2003-11-01 · usefulness score 61/100 · Treatments
• A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease Archives of neurology · 2010-09-13 · usefulness score 70/100 · Treatments
• A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease Alzheimer disease and associated disorders · 2007-04-01 · usefulness score 67/100 · Treatments

Similar studies

• Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease 2018 · Inflammation and the immune system
• Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice 2012 · Risk genes beyond APOE
• Mechanisms of action of formononetin, an extract from Astragalus membranaceus medicinal plant, in ameliorating Alzheimer’s disease 2025 · Disease mechanisms
• Natural compounds as multitarget agents in Alzheimer's diseases: evidence from <i>in vivo</i> and <i>in vitro</i> models 2026 · Inflammation and the immune system
• Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs 2023 · Disease mechanisms
• Signalling Pathways Involved in Microglial Activation in Alzheimer's Disease and Potential Neuroprotective Role of Phytoconstituents 2024 · Drug development

More on Risk genes beyond APOE

• A review that covers this ground Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate] Cellular and molecular neurobiology · 2001-12-01 · usefulness score 39/100
• Newest in this subject Pregnancy History and Loss of Normal PSEN2 Function Impact Female Late-Life Cognitive Processing, Inhibitory Signaling, and Gliosis bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Temporal Proteomics Links the APP London Mutation to Early Cholesterol Remodeling Cell Programs in Human Neurons bioRxiv · 2026-10-24 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Risk genes beyond APOE →